Literature DB >> 10197442

Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas.

M Ostergaard1, H Wolf, T F Orntoft, J E Celis.   

Abstract

To search for bladder squamous cell carcinoma markers that are released to the urine a blind and systematic analysis of the protein profiles of fresh tumors, their secreted proteins, as well as the patient's urine was carried out using state-of-the-art proteomic technology. We review the data concerning the putative marker psoriasin (S100A7), which, alone or in combination with other biomarkers, may be valuable for the noninvasive follow-up of patients bearing these tumors.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10197442     DOI： 10.1002/(SICI)1522-2683(19990201)20:2<349::AID-ELPS349>3.0.CO;2-B

Source DB:  PubMed          Journal:  Electrophoresis        ISSN： 0173-0835            Impact factor:   3.535


  19 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Role of oncostatin M in the pathogenesis of vernal keratoconjunctivitis: focus on tissue remodeling.

Authors:  Keitaro Mashimo; Ayumi Usui-Ouchi; Yousuke Ito; Rei Wakasa-Arai; Norihiko Yokoi; Satoshi Kawasaki; Akira Murakami; Akira Matsuda; Nobuyuki Ebihara
Journal:  Jpn J Ophthalmol       Date:  2021-01-06       Impact factor: 2.447

3.  Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.

Authors:  Xuefeng B Ling; Kenneth Lau; Chetan Deshpande; Jane L Park; Diana Milojevic; Claudia Macaubas; Chris Xiao; Viorica Lopez-Avila; John Kanegaye; Jane C Burns; Harvey Cohen; James Schilling; Elizabeth D Mellins
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

4.  Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Authors:  Julio E Celis; José M A Moreira; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans; Fritz Rank
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

5.  Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Authors:  Julio E Celis; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans-Wielenga; Fritz Rank; José M A Moreira
Journal:  Mol Oncol       Date:  2007-09-25       Impact factor: 6.603

6.  Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.

Authors:  José M A Moreira; Gita Ohlsson; Pavel Gromov; Ronald Simon; Guido Sauter; Julio E Celis; Irina Gromova
Journal:  Mol Cell Proteomics       Date:  2009-09-25       Impact factor: 5.911

7.  Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.

Authors:  Weiguo Wu; Ximing Tang; Wei Hu; Reuben Lotan; Waun Ki Hong; Li Mao
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

8.  Intermittent self-catheterization and the risk of squamous cell cancer of the bladder: An emerging clinical entity?

Authors:  Rowan G Casey; Ivor M Cullen; Tom Crotty; David M Quinlan
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

9.  Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation.

Authors:  Yan Zheng; François Niyonsaba; Hiroko Ushio; Shigaku Ikeda; Isao Nagaoka; Ko Okumura; Hideoki Ogawa
Journal:  Immunology       Date:  2008-01-08       Impact factor: 7.397

10.  Immunoexpression analysis and prognostic value of BLCAP in breast cancer.

Authors:  Irina Gromova; Pavel Gromov; Niels Kroman; Vera Timmermans Wielenga; Ronald Simon; Guido Sauter; José M A Moreira
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.